Older patients in the nephrology clinic - Should they be referred?

New Zealand Medical Journal

Volumn 118, Issue 1225, 2005, Pages

  Lynn, Sarah ^a   Sainsbury, Richard ^a   Searle, Martin ^b  

^a PRINCESS MARGARET HOSPITAL   (New Zealand)

^b CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CREATININE; PREDNISONE;

ACUTE DISEASE; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CHRONIC GLOMERULONEPHRITIS; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DISEASE SEVERITY; ELDERLY CARE; FEMALE; FOCAL GLOMERULOSCLEROSIS; GENERAL PRACTITIONER; HUMAN; HUMAN TISSUE; KIDNEY ARTERY STENOSIS; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MULTIPLE MYELOMA; OUTCOMES RESEARCH; PATIENT MONITORING; PATIENT REFERRAL; PERITONEAL DIALYSIS; PRACTICE GUIDELINE; RENOVASCULAR HYPERTENSION; RETROSPECTIVE STUDY; SARCOIDOSIS; TREATMENT PLANNING; VASCULITIS; BLOOD; CLINICAL PRACTICE; ECHOGRAPHY; GENERAL PRACTICE; HEMATURIA; HOSPITAL ADMISSION; HYPERTENSION; KIDNEY; METABOLISM; NEPHROLOGY; PROTEINURIA; STATISTICS; URINALYSIS; URINE;

AGED; AGED, 80 AND OVER; CREATININE; FAMILY PRACTICE; FEMALE; HEMATURIA; HUMANS; HYPERTENSION; KIDNEY; KIDNEY DISEASES; MALE; NEPHROLOGY; PHYSICIAN'S PRACTICE PATTERNS; PROTEINURIA; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; URINALYSIS; WAITING LISTS;

EID: 27944495240     PISSN: 11758716     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Davies DF, Shock NW. Age changes in glomerular filtration rate, effective renal plasma flow and tubular excretory capacity in adult males. J Clin Invest. 1950;29:496-507.
2. Excell L, McDonald S. New patients commencing treatment in 2003 (pp 8-14). ANZDATA Registry Report 2004. Adelaide, South Australia: Australia and New Zealand Dialysis and Transplant Registry; 2004
3. U.S. Renal Data System, USRDS 2003 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2003.
4. Luke RG, Beck LH. Gerontologizing Nephrology. J Am Soc Nephrol. 1999;10:1824-7.
5. National Referral Guidelines: Renal Medicine. Wellington: Elective Services, HFA; 2000. Available online. URL: http://www.electiveservices.govt.nz/pdfs/Renal-Medicine-Referral.pdf Accessed November 2005.
6. Collins JF. Who should receive dialysis? New Ethicals Journal. 1998;August:13-19.
7. Lynn KL, Smith AH, Inkster JA, et al. Audit of the outcome of patients with renal failure presenting to a regional nephrology service. N Z Med J. 1996;109:295-7.
8. Cass A, Cunningham J, Arnold PC, et al. Delayed referral to a nephrologist: outcomes among patients who survive at least one year on dialysis. Med J Aust. 2002;177:135-8.
9. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
10. Chadban SJ, Briganti EM, Kerr PG, et al. Prevalence of Kidney Damage in Australian Adults: The AusDiab Kidney Study. J Am Soc Nephrol. 2003;14:S131-8
11. The Caring for Australians with Renal Impairment (CARI) guidelines. Early referral of patients with kidney disease. NSW, Australia: CARI. Available online. URL: http://www.cari.org.au/guidelines.php Accessed November 2005.
12. Sesso R, Belasco AG. Late diagnosis of chronic renal failure and mortality on maintenance dialysis. Nephrol Dial Transplant. 1996;11:2417-20.
13. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-52.
14. Krishnan M, Lok CE, Jassal SV. Epidemiology and Demographic Aspects of Treated End-Stage Renal Disease in the Elderly. Seminars in Dialysis. 2002;15:79-83.
15. MDRD Study Group. Blood pressure control, proteinuria, and the progression of renal disease. Ann Intern Med. 1995;123:754-62.
16. Ruggenenti P, Perna A, Mosconi L, et al. Urinary protein excretion rate in the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN) Kidney Int. 1998;53:1209-16.
17. Maki DD, Ma JZ, Louis TA, et al. Long-term effects of antihypertensive agents on proteinuria and renal function. Arch Intern Med. 1995;155:1073-80.
18. Jafar TH, Schmid CH, Landa M, et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med. 2001;135:73-87.
19. Giatras I, Lau J, Levey AS. Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting Enzyme Inhibition and Progressive Renal Disease Study Group. Ann Intern Med. 1997;127:337-45.
20. Bakris GL, Weir MR. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern. Arch Intern Med. 2000;160:685-93.
21. Knight JF. An introduction to the KidneyCheck Australia Taskforce. Nephrology. 2002;7:S33-5.
22. Johnson DW. Evidence-based guide to slowing the progression of early renal insufficiency. Intern Med J. 2004;34:50-7.
23. Excell L, McDonald S. Method and location of dialysis (pp 26-33). ANZDATA Registry Report 2004. Adelaide, South Australia: Australia and New Zealand Dialysis and Transplant Registry.